Abstract:Introduction: In the field of solid organ transplantation, two different areas have developed: the use of biomarkers to predict allograft tolerance, and biomarkers for the prediction of allograft rejection. In the present study, we stimulate the peripheral blood lymphocytes (PBL) of kidney transplant recipients in vitro, and detect the expression of cell culture supernatant IL-2 and IL-6 or cell surface CD69 and CD71 by flow cytometric microcarrier assay (FCMA) to predict acute rejection. Methods: Forty kidney transplant recipients underwent kidney transplantation with living-related donor were selected as objects and divided into two groups that normal function (n=20) and acute rejection (n=20), and 10 healthy volunteers were selected as healthy control. Stimulate all objects PBL for 8 hours by phorbol myfismte acetate and ionomycin, and detect the expression of cell culture supernatant IL-2 and IL-6 or cell surface CD69 and CD71 by FCMA that polymer microspheres conjunct with probe and hybridize with ligand which waiting for test, and measure the fluorescence signal of probe by flow cytometry. The sensitivity and specificity of the method predict acute rejection by combine IL-2 and IL-6 or CD69 and CD71, which was analyzed by the curve of receiver operating characteristic (ROC). The study was approved by the local ethical committee. Results: The fluorescence intensity of IL-2 and IL-6 in healthy control were 108.82±65.30 and 983.97±896.88, respectively, and significant higher than group of normal function (26.11±11.31 and 105.36±61.60, respectively, P< 0.001, Figure 1 A/B). The fluorescence intensity of IL-2 and IL-6 in acute rejection (81.03±37.66 and 260.77±99.97, respectively.) significant higher than group of normal function (P< 0.01). The proportion of CD3+CD69+ and CD3+CD71+ T cell in group of healthy control were (37.28±20.43)% and (36.07±18.83)%, respectively, and significant higher than group of normal function [(7.66±2.88)% and (6.91±3.03)%, respectively, P< 0.001, Figure 1 C/D]. The proportion of CD3+CD69+ and CD3+CD71+ T cell in group of acute rejection [(23.27±15.37)% and (27.56±17.91)%, respectively] significant higher than group of normal function (P< 0.01). The sensitivity and specificity for predict acute rejection were 90% and 95%, respectively, when analyzed by the curve of ROC with combine IL-2 and IL-6. The sensitivity and specificity for predict acute rejection combines CD69 and CD71 were 95% and90%, respectively.[Figure 1 The results of FCMA (*P<0.05).]Conclusions: This study showed FCMA was a new method with high sensitivity and specificity. Monitoring the expression of cell culture supernatant IL-2 and IL-6 or cell surface CD69 and CD71 after stimulate the PBL of kidney transplant recipients in vitro by FCMA, which could predict acute rejection and provides an important reference for the early diagnosis of kidney rejection.

Long-distance IMEG Monitoring of Acute Rejection after Heart Transplantation

Intramyocardial Electrocardiogram in Diagnosis of Acute Rejection after Heart Transplantation

Intramyocardial Electrocardiogram Measurements for Diagnosis of Acute Cardiac Allograft Rejection in Rats

[Experiences of Applying Home Monitoring for Cardiac Implantable Electronic Devices].

Noninvasive monitoring of acute rejection after allogenic cardiac transplantation

Molecular Imaging of Acute Cardiac Transplant Rejection: Animal Experiments and Prospects.

Noninvasive Radionuclide Molecular Imaging of the CD4-Positive T Lymphocytes in Acute Cardiac Rejection.

A Novel Noninvasive Method to Detect Rejection after Heart Transplantation

Ultrasound Molecular Imaging of Acute Cardiac Transplantation Rejection Using Nanobubbles Targeted to T Lymphocytes

Application of immune cell functional assay in monitoring immune status in renal transplant recipients

Myocardial tissue characterisation by Cardiovascular Magnetic Resonance diagnoses and tracks recovery after cardiac transplant rejection

Non‐invasive parameters for detection of cardiac allograft rejection

The role of speckle tracking imaging in the noninvasive detection of acute rejection after heterotopic cardiac transplantation in rats.

Evaluation of Acute Cardiac Transplant Rejection with Targeted Myocardial Contrast Echocardiography

Histopathological Characteristics of Percutaneous Endomyocardial Biopsy in Heart Transplant Rejection Surveillance: A Single Center Experience

Amplification of Plasma MicroRNAs for Non-invasive Early Detection of Acute Rejection after Heart Transplantation With Ultrasound-Targeted Microbubble Destruction

Cytoimmunological monitoring of heart transplant recipients

Evaluating acute rejection after heterotopic cardiac transplantation in rats by speckle tracking imaging

The Immune Monitoring in Kidney Transplant Recipients Could Predict Acute Rejection by a New Method: Flow Cytometric Microcarrier Assay

Issues of Immunological and Hemodynamic Monitoring Before and During Kidney Transplantation in Sensitized Heart Transplant Recipient

1151: Ability of Tissue Doppler and Strain/Strain Rate Imaging to Identify Patients who have Acute Rejection after Cardiac Transplantation